Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Stahmann

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 2, 2022
Comparison of employment among people with Multiple Sclerosis across EuropeDavid Ellenberger, Tina Parciak, Waldemar Brola, et al.
Frontiers in Neurology|October 5, 2020
Management of MS Patients Treated With Daclizumab - a Case Series of 267 PatientsPaulus S Rommer, Klaus Berger, David Ellenberger, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 8, 2025
Paediatric-onset multiple sclerosis: demographics, symptoms and disease progressionDavid Ellenberger, Peter Flachenecker, Judith Haas, et al.
Multiple Sclerosis and Related Disorders|September 27, 2020
Is benign MS really benign? What a meaningful classification beyond the EDSS must take into considerationDavid Ellenberger, Peter Flachenecker, Judith Haas, et al.
Journal of Neurology|September 4, 2025
Age-related differences in switching highly effective disease-modifying therapy in patients with multiple sclerosisDavid Ellenberger, Niklas Frahm, Alexander Stahmann, et al.
European Journal of Neurology|July 9, 2021
Prevalence of pediatric multiple sclerosis in Germany: A nationwide population-based analysisNiklas Frahm, Melanie Peters, Jörg Bätzing, et al.
Multiple Sclerosis and Related Disorders|October 8, 2021
Characteristics of secondary progressive multiple sclerosis: Disease activity and provision of care in Germany - A registry-based/multicentric cohort studyNiklas Frahm, David Ellenberger, Firas Fneish, et al.
Trials|February 15, 2021
Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)-study protocol for a randomised controlled trialAnne Christin Rahn, Lisa Wenzel, Andrea Icks, et al.
Therapeutic Advances in Neurological Disorders|October 14, 2021
Treatment patterns in pediatric patients with multiple sclerosis in Germany-a nationwide claim-based analysisNiklas Frahm, Melanie Peters, Jörg Bätzing, et al.
Scientific Reports|June 26, 2021
Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registryLisa-Marie Ohle, David Ellenberger, Peter Flachenecker, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 2, 2022
Comparison of employment among people with Multiple Sclerosis across EuropeDavid Ellenberger, Tina Parciak, Waldemar Brola, et al.
Frontiers in Neurology|October 5, 2020
Management of MS Patients Treated With Daclizumab - a Case Series of 267 PatientsPaulus S Rommer, Klaus Berger, David Ellenberger, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 8, 2025
Paediatric-onset multiple sclerosis: demographics, symptoms and disease progressionDavid Ellenberger, Peter Flachenecker, Judith Haas, et al.
Multiple Sclerosis and Related Disorders|September 27, 2020
Is benign MS really benign? What a meaningful classification beyond the EDSS must take into considerationDavid Ellenberger, Peter Flachenecker, Judith Haas, et al.
Journal of Neurology|September 4, 2025
Age-related differences in switching highly effective disease-modifying therapy in patients with multiple sclerosisDavid Ellenberger, Niklas Frahm, Alexander Stahmann, et al.
European Journal of Neurology|July 9, 2021
Prevalence of pediatric multiple sclerosis in Germany: A nationwide population-based analysisNiklas Frahm, Melanie Peters, Jörg Bätzing, et al.
Multiple Sclerosis and Related Disorders|October 8, 2021
Characteristics of secondary progressive multiple sclerosis: Disease activity and provision of care in Germany - A registry-based/multicentric cohort studyNiklas Frahm, David Ellenberger, Firas Fneish, et al.
Trials|February 15, 2021
Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)-study protocol for a randomised controlled trialAnne Christin Rahn, Lisa Wenzel, Andrea Icks, et al.
Therapeutic Advances in Neurological Disorders|October 14, 2021
Treatment patterns in pediatric patients with multiple sclerosis in Germany-a nationwide claim-based analysisNiklas Frahm, Melanie Peters, Jörg Bätzing, et al.
Scientific Reports|June 26, 2021
Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registryLisa-Marie Ohle, David Ellenberger, Peter Flachenecker, et al.
Pageof 5